Accumulating evidences also confirm that the activation of NTS/NTSR1 complex results in cancer progression and poor prognosis in breast cancer, malignant pleural mesothelioma, and head and neck squamous cell carcinomas [6,7]. This evidence concerns the gene NTSR1 and breast cancer.